136 related articles for article (PubMed ID: 10187778)
41. Presence of an unusual GM2 derivative, taurine-conjugated GM2, in Tay-Sachs brain.
Li YT; Maskos K; Chou CW; Cole RB; Li SC
J Biol Chem; 2003 Sep; 278(37):35286-91. PubMed ID: 12829702
[TBL] [Abstract][Full Text] [Related]
42. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.
Inui K; Grebner EE; Jackson LG; Wenger DA
Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417
[TBL] [Abstract][Full Text] [Related]
43. Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel.
Ishikawa Y; Li SC; Wood PA; Li YT
J Neurochem; 1987 Mar; 48(3):860-4. PubMed ID: 2949061
[TBL] [Abstract][Full Text] [Related]
44. Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model.
Martino S; Cavalieri C; Emiliani C; Dolcetta D; Cusella De Angelis MG; Chigorno V; Severini GM; Sandhoff K; Bordignon C; Sonnino S; Orlacchio A
Neurochem Res; 2002 Aug; 27(7-8):793-800. PubMed ID: 12374215
[TBL] [Abstract][Full Text] [Related]
45. Isolation and characterization of a novel monosialosylpentahexosyl ceramide from Tay-Sachs brain.
Itoh T; Li YT; Li SC; Yu RK
J Biol Chem; 1981 Jan; 256(1):165-9. PubMed ID: 7451432
[TBL] [Abstract][Full Text] [Related]
46. Substrate binding properties of the human liver hexosaminidase A activator protein.
Hechtman P; Isaacs C; Smith-Jones L
Can J Biochem Cell Biol; 1985 Aug; 63(8):830-8. PubMed ID: 2933135
[TBL] [Abstract][Full Text] [Related]
47. Biochemical characterization of the Cys138Arg substitution associated with the AB variant form of GM2 gangliosidosis: evidence that Cys138 is required for the recognition of the GM2 activator/GM2 ganglioside complex by beta-hexosaminidase A.
Xie B; Rigat B; Smiljanic-Georgijev N; Deng H; Mahuran D
Biochemistry; 1998 Jan; 37(3):814-21. PubMed ID: 9454570
[TBL] [Abstract][Full Text] [Related]
48. Preparation and enzymatic degradation of monosulfogangliotriaosylceramide.
Ishizuka I; Nagai K; Kawaguchi K; Tadano-Aritomi K; Toida T; Hirabayashi Y; Li YT; Li SC
J Biol Chem; 1985 Sep; 260(20):11256-61. PubMed ID: 3928630
[TBL] [Abstract][Full Text] [Related]
49. Large-scale in vivo synthesis of the carbohydrate moieties of gangliosides GM1 and GM2 by metabolically engineered Escherichia coli.
Antoine T; Priem B; Heyraud A; Greffe L; Gilbert M; Wakarchuk WW; Lam JS; Samain E
Chembiochem; 2003 May; 4(5):406-12. PubMed ID: 12740812
[TBL] [Abstract][Full Text] [Related]
50. Evidence for sialidase hydrolyzing gangliosides GM2 and GM1 in rat liver plasma membrane.
Miyagi T; Tsuiki S
FEBS Lett; 1986 Oct; 206(2):223-8. PubMed ID: 3758350
[TBL] [Abstract][Full Text] [Related]
51. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.
Raghavan SS; Krusell A; Krusell J; Lyerla TA; Kolodny EH
Am J Hum Genet; 1985 Nov; 37(6):1071-82. PubMed ID: 2934978
[TBL] [Abstract][Full Text] [Related]
52. The Sda/GM2-glycan is a carbohydrate marker of porcine primordial germ cells and of a subpopulation of spermatogonia in cattle, pigs, horses and llama.
Klisch K; Contreras DA; Sun X; Brehm R; Bergmann M; Alberio R
Reproduction; 2011 Nov; 142(5):667-74. PubMed ID: 21896636
[TBL] [Abstract][Full Text] [Related]
53. The GM2-gangliosidoses and the elucidation of the beta-hexosaminidase system.
Sandhoff K
Adv Genet; 2001; 44():67-91. PubMed ID: 11597000
[No Abstract] [Full Text] [Related]
54. GM2 ganglioside activator occurs in multiple forms.
Novak A; Lowden JA
Biochim Biophys Acta; 1994 Mar; 1199(2):209-14. PubMed ID: 8123670
[TBL] [Abstract][Full Text] [Related]
55. [Recent advances in molecular genetics of GM2 gangliosidosis].
Wakamatsu N
Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
[TBL] [Abstract][Full Text] [Related]
56. Isolation and characterization of an activator protein for the hydrolysis of ganglioside GM2 from the roe of striped mullet (Mugil cephalus).
DeGasperi R; Li YT; Li SC
Biochem J; 1989 Jun; 260(3):777-83. PubMed ID: 2527497
[TBL] [Abstract][Full Text] [Related]
57. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
Harzer K
Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344
[No Abstract] [Full Text] [Related]
58. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.
Phaneuf D; Wakamatsu N; Huang JQ; Borowski A; Peterson AC; Fortunato SR; Ritter G; Igdoura SA; Morales CR; Benoit G; Akerman BR; Leclerc D; Hanai N; Marth JD; Trasler JM; Gravel RA
Hum Mol Genet; 1996 Jan; 5(1):1-14. PubMed ID: 8789434
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K
Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574
[TBL] [Abstract][Full Text] [Related]
60. The N-acetylgalactosamine residue of exogenous GM2 ganglioside is recycled for glycoconjugate biosynthesis in rat liver.
Trinchera M; Ghidoni R; Greggia L; Tettamanti G
Biochem J; 1990 Feb; 266(1):103-6. PubMed ID: 2310367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
